Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.
about
Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerationsAlternative donor transplant of benign primary hematologic disordersHematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.Sickle cell disease: time for a closer look at treatment options?Hematopoietic stem cell transplantation for sickle cell disease: state of the science.Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis.Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.The Safe Recipient of SSC Transplantation Prepared by Heat Shock With Busulfan Treatment in Mice
P2860
Q26800236-4B43F4F8-0C28-4126-AED6-522F276AA29CQ26823398-83923767-A0AE-4D92-8C16-F1860FAB2D79Q34625467-5FE1D832-90D1-4DF0-BDCA-6399592B5E02Q35634116-61EE26D5-CE0A-4E85-867E-AEB55372478BQ36777485-C13BA314-EB28-47CE-8FEF-25D17A45526CQ37627281-07BD1556-9F52-45FB-924A-D8153DA6DAFFQ38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73EQ38247055-24FF2CFA-E222-4AFF-A8AE-EE26AAA6DA23Q41536298-CDEE4337-54AA-4612-8115-5EB66F5DF61DQ41592113-4515DB16-9F7A-4030-8BA1-A3248D24F485Q47614526-2F6A725C-F9D8-45C1-90D2-766A44B328A6Q58760598-93BBA8D9-99AB-4743-A038-F50588901EE6
P2860
Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@en
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@nl
type
label
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@en
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@nl
prefLabel
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@en
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@nl
P2093
P1476
Busulfan, fludarabine, and ale ...... dren with sickle cell disease.
@en
P2093
Courtney Baker
Erin Morris
Gustavo Del Toro
Kavita Radhakrishnan
Lauren Harrison
Lee Ann Baxter-Lowe
Mitchell S Cairo
Monica Bhatia
Zhezhen Jin
P304
P356
10.1016/J.BBMT.2013.02.002
P50
P577
2013-02-09T00:00:00Z